# Implantation or Injectable Dosage Form New Animal Drugs; Tilmicosin
> **Food and Drug Administration** · Final rule. · Published 2010-03-02 · Effective 2010-03-02 · 75 FR 9333
## Document
- **Document number:** 2010-4206
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 75 FR 9333
- **CFR reference:** 21 CFR 522
- **Publication date:** 2010-03-02
- **Effective date:** 2010-03-02
- **HHS docket:** Docket No. FDA-2010-N-0002
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA provides a dose range for use of an injectable solution of tilmicosin phosphate for treatment of respiratory disease in cattle and additional pathogens for which this therapy is effective.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2010/03/02/2010-4206/implantation-or-injectable-dosage-form-new-animal-drugs-tilmicosin)
---
*AI Analytics · CC0 1.0*